Lingzi Su
Shanghai, 200437, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Response to Letter to the Editor Regarding "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study" in Integrative Cancer Therapies.
Journal: Integrative cancer therapies
Published: February 12, 2026
Association between advanced lung cancer inflammation index and postoperative mortality in lung cancer patients: a retrospective cohort study.
Journal: European journal of medical research
Published: July 27, 2025
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study.
Journal: Integrative cancer therapies
Published: February 07, 2025
Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages.
Journal: Medical oncology (Northwood, London, England)
Published: November 02, 2024
Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial.
Journal: BMC complementary medicine and therapies
Published: July 28, 2024
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation.
Journal: Frontiers in immunology
Published: July 18, 2024
Chinese Herbal Medicine Combined With Liuzijue Exercise in Physiological Rehabilitation After Video-assisted Lung Lobectomy for Cancer: A Prospective Propensity Score Matching Study.
Journal: Integrative cancer therapies
Published: June 22, 2024
Chinese Herbal Medicine (Yiqi-Yangyin-Jiedu Decoction) Combined With Osimertinib as First-Line Treatment in EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (CATLA-2): A Study Protocol for a Double-Blind Randomized Controlled Trial.
Journal: Frontiers in pharmacology
Published: December 21, 2021
Malignant mesothelioma without asbestos exposure diagnosed during EGFR-TKI treatment of lung adenocarcinoma: A case report.
Journal: Cancer treatment and research communications
Published: December 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026